Literature DB >> 22652199

Dynamic regulation of platelet-derived growth factor receptor α expression in alveolar fibroblasts during realveolarization.

Leiling Chen1, Thomas Acciani, Tim Le Cras, Carolyn Lutzko, Anne-Karina T Perl.   

Abstract

Although the importance of platelet-derived growth factor receptor (PDGFR)-α signaling during normal alveogenesis is known, it is unclear whether this signaling pathway can regulate realveolarization in the adult lung. During alveolar development, PDGFR-α-expressing cells induce α smooth muscle actin (α-SMA) and differentiate to interstitial myofibroblasts. Fibroblast growth factor (FGF) signaling regulates myofibroblast differentiation during alveolarization, whereas peroxisome proliferator-activated receptor (PPAR)-γ activation antagonizes myofibroblast differentiation in lung fibrosis. Using left lung pneumonectomy, the roles of FGF and PPAR-γ signaling in differentiation of myofibroblasts from PDGFR-α-positive precursors during compensatory lung growth were assessed. FGF receptor (FGFR) signaling was inhibited by conditionally activating a soluble dominant-negative FGFR2 transgene. PPAR-γ signaling was activated by administration of rosiglitazone. Changes in α-SMA and PDGFR-α protein expression were assessed in PDGFR-α-green fluorescent protein (GFP) reporter mice using immunohistochemistry, flow cytometry, and real-time PCR. Immunohistochemistry and flow cytometry demonstrated that the cell ratio and expression levels of PDGFR-α-GFP changed dynamically during alveolar regeneration and that α-SMA expression was induced in a subset of PDGFR-α-GFP cells. Expression of a dominant-negative FGFR2 and administration of rosiglitazone inhibited induction of α-SMA in PDGFR-α-positive fibroblasts and formation of new septae. Changes in gene expression of epithelial and mesenchymal signaling molecules were assessed after left lobe pneumonectomy, and results demonstrated that inhibition of FGFR2 signaling and increase in PPAR-γ signaling altered the expression of Shh, FGF, Wnt, and Bmp4, genes that are also important for epithelial-mesenchymal crosstalk during early lung development. Our data demonstrate for the first time that a comparable epithelial-mesenchymal crosstalk regulates fibroblast phenotypes during alveolar septation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652199      PMCID: PMC3488620          DOI: 10.1165/rcmb.2012-0030OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  82 in total

1.  Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice.

Authors:  H Fehrenbach; R Voswinckel; V Michl; T Mehling; A Fehrenbach; W Seeger; J R Nyengaard
Journal:  Eur Respir J       Date:  2007-11-21       Impact factor: 16.671

2.  Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats.

Authors:  Dong Liu; Bang-Xiong Zeng; Shi-Hai Zhang; Yue-Lan Wang; Lian Zeng; Zhi-Long Geng; Shi-Fan Zhang
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

3.  Levels of mesenchymal FGFR2 signaling modulate smooth muscle progenitor cell commitment in the lung.

Authors:  Stijn P De Langhe; Gianni Carraro; David Warburton; Mohammad K Hajihosseini; Saverio Bellusci
Journal:  Dev Biol       Date:  2006-07-07       Impact factor: 3.582

4.  Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo.

Authors:  Virender K Rehan; Ying Wang; Sanjay Patel; Jamie Santos; John S Torday
Journal:  Pediatr Pulmonol       Date:  2006-06

5.  PPAR-gamma agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis.

Authors:  Jami E Milam; Venkateshwar G Keshamouni; Sem H Phan; Biao Hu; Srinivasa R Gangireddy; Cory M Hogaboam; Theodore J Standiford; Victor J Thannickal; Raju C Reddy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-12-27       Impact factor: 5.464

6.  Peroxisome proliferator-activated receptors as novel targets in lung disease.

Authors:  Maria G Belvisi; David J Hele
Journal:  Chest       Date:  2008-07       Impact factor: 9.410

7.  An FGF-WNT gene regulatory network controls lung mesenchyme development.

Authors:  Yongjun Yin; Andrew C White; Sung-Ho Huh; Matthew J Hilton; Hidemi Kanazawa; Fanxin Long; David M Ornitz
Journal:  Dev Biol       Date:  2008-06-03       Impact factor: 3.582

8.  Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model.

Authors:  Ying Wang; Jamie Santos; Reiko Sakurai; Eugene Shin; Laura Cerny; John S Torday; Virender K Rehan
Journal:  Pediatr Res       Date:  2009-02       Impact factor: 3.756

9.  Platelet-derived growth factor receptor-alpha-expressing cells localize to the alveolar entry ring and have characteristics of myofibroblasts during pulmonary alveolar septal formation.

Authors:  Stephen E McGowan; Ruth E Grossmann; Patricia W Kimani; Amey J Holmes
Journal:  Anat Rec (Hoboken)       Date:  2008-12       Impact factor: 2.064

10.  Role of Fgf receptor 2c in adipocyte hypertrophy in mesenteric white adipose tissue.

Authors:  Morichika Konishi; Hirotoshi Nakamura; Hiroyuki Miwa; Pierre Chambon; David M Ornitz; Nobuyuki Itoh
Journal:  Mol Cell Endocrinol       Date:  2008-02-19       Impact factor: 4.102

View more
  81 in total

1.  Diversity of Interstitial Lung Fibroblasts Is Regulated by Platelet-Derived Growth Factor Receptor α Kinase Activity.

Authors:  Jenna Green; Mehari Endale; Herbert Auer; Anne-Karina T Perl
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

Review 2.  Comparative analysis of the mechanical signals in lung development and compensatory growth.

Authors:  Connie C W Hsia
Journal:  Cell Tissue Res       Date:  2017-01-13       Impact factor: 5.249

3.  Regulation of fibroblast lipid storage and myofibroblast phenotypes during alveolar septation in mice.

Authors:  Stephen E McGowan; Diann M McCoy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-08-22       Impact factor: 5.464

Review 4.  In Vitro Models to Study Human Lung Development, Disease and Homeostasis.

Authors:  Alyssa J Miller; Jason R Spence
Journal:  Physiology (Bethesda)       Date:  2017-05

5.  Type 2 alveolar cells are stem cells in adult lung.

Authors:  Christina E Barkauskas; Michael J Cronce; Craig R Rackley; Emily J Bowie; Douglas R Keene; Barry R Stripp; Scott H Randell; Paul W Noble; Brigid L M Hogan
Journal:  J Clin Invest       Date:  2013-06-10       Impact factor: 14.808

Review 6.  Fibroblasts and the ground they walk on.

Authors:  Daniel J Tschumperlin
Journal:  Physiology (Bethesda)       Date:  2013-11

7.  Heterogeneity of Fibroblasts and Myofibroblasts in Pulmonary Fibrosis.

Authors:  David M Habiel; Cory M Hogaboam
Journal:  Curr Pathobiol Rep       Date:  2017-05-02

8.  An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.

Authors:  Daniel J Weiss; Daniel Chambers; Adam Giangreco; Armand Keating; Darrell Kotton; Peter I Lelkes; Darcy E Wagner; Darwin J Prockop
Journal:  Ann Am Thorac Soc       Date:  2015-04

9.  Fibroblast growth factor signaling in myofibroblasts differs from lipofibroblasts during alveolar septation in mice.

Authors:  Stephen E McGowan; Diann M McCoy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-07-02       Impact factor: 5.464

10.  Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.

Authors:  Hongmei Gu; Amanda J Fisher; Elizabeth A Mickler; Frank Duerson; Oscar W Cummings; Marc Peters-Golden; Homer L Twigg; Trent M Woodruff; David S Wilkes; Ragini Vittal
Journal:  FASEB J       Date:  2016-03-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.